Gotowa bibliografia na temat „Anti diabetic drugs”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Anti diabetic drugs”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Anti diabetic drugs"
Ulfa, Ridha, Syarifah NYRS Assegaf, and Mistika Zakia. "PEDULI PENYAKIT TIDAK MENULAR DENGAN SKRINING KESEHATAN, BEDAH BUKU DAN PENYULUHAN PENGGUNAAN OBAT ANTI DIABETIK, OBAT HIPERURISEMIA DAN OBAT DISLIPIDEMIA YANG RASIONAL." Medical Dedication (medic) : Jurnal Pengabdian kepada Masyarakat FKIK UNJA 5, no. 1 (2022): 396–402. http://dx.doi.org/10.22437/medicaldedication.v5i1.18681.
Pełny tekst źródłaNanda, Oryza Dwi, Bambang Wiryanto, and Erwin Astha Triyono. "Hubungan Kepatuhan Minum Obat Anti Diabetik dengan Regulasi Kadar Gula Darah pada Pasien Perempuan Diabetes Mellitus." Amerta Nutrition 2, no. 4 (2018): 340. http://dx.doi.org/10.20473/amnt.v2i4.2018.340-348.
Pełny tekst źródłaWalia, Smily, J. S. Dua, and D. N. Prasad. "Herbal Drugs with Anti-Diabetic Potential." Journal of Drug Delivery and Therapeutics 11, no. 6 (2021): 248–56. http://dx.doi.org/10.22270/jddt.v11i6.5051.
Pełny tekst źródłaSasikumar, Amithkumar, and Sheetal S. "Bruns–Garland syndrome precipitated by anti-tuberculous therapy in a patient with type 2 diabetes mellitus." Nepal Journal of Neuroscience 19, no. 1 (2022): 66–67. http://dx.doi.org/10.3126/njn.v19i1.40952.
Pełny tekst źródłaShaha, Kartick Chanda, Sharmin Jahan, Md Ziaur Rahman Mamun, Md Shafiqur Rahman, Farjana Ahmed, and Bhagyashree Karmokar Jyoti. "Prescribing patterns of anti-diabetic drugs among type 2 diabetic patients at a private Medical College Hospital in Mymensingh." Journal of Dhaka National Medical College & Hospital 23, no. 1 (2017): 29–32. https://doi.org/10.3329/jdnmch.v23i1.78063.
Pełny tekst źródłaSiddhi, Nigade* Dinesh Ingole Arundhati Kore Jagruti Shelar. "Review On Anti-Diabetic Drug and Treatment." International Journal of Pharmaceutical Sciences 3, no. 6 (2025): 185–95. https://doi.org/10.5281/zenodo.15574490.
Pełny tekst źródłaSingh, Ved Prakash. "An Overview on Anti Diabetic Drugs and Development." Science & Technology Journal 4, no. 2 (2016): 113–23. http://dx.doi.org/10.22232/stj.2016.04.02.05.
Pełny tekst źródłaDevkota, HP, A. Adhikari-Devkota, S. Yahara, and P. Basnet. "Anti-oxidative Activity of Nepalese Traditional Anti-diabetic Medicines." Nepal Journal of Science and Technology 14, no. 2 (2014): 151–54. http://dx.doi.org/10.3126/njst.v14i2.10429.
Pełny tekst źródłaKapur, Ajita, Harmeet Singh Rehan, Lalit Kumar Gupta, and Madhur Yadav. "Pattern of anti-diabetic drugs prescribed for type 2 diabetes mellitus patients in a tertiary care hospital of India: an observational study." International Journal of Basic & Clinical Pharmacology 8, no. 7 (2019): 1657. http://dx.doi.org/10.18203/2319-2003.ijbcp20192667.
Pełny tekst źródłaGalstyan, Gagik R., Ekaterina A. Shestakova, and Igor A. Sklyanik. "Obesity and type 2 diabetes: can we find a compromised treatment solution?" Diabetes mellitus 20, no. 4 (2017): 270–78. http://dx.doi.org/10.14341/dm8726.
Pełny tekst źródłaRozprawy doktorskie na temat "Anti diabetic drugs"
Hoa, Nguyen Khanh. "Assessment of anti-diabetic effect of Vietnamese herbal drugs /." Stockholm, 2005. http://diss.kib.ki.se/2005/91-7140-585-2/.
Pełny tekst źródłaLennox, Rachael. "Actions of anti-diabetic drugs on hippocampal dependent cognitive function in obesity and type 2 diabetes." Thesis, Ulster University, 2014. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.667766.
Pełny tekst źródłaLi, Xiaoxiao. "Ranolazine: a Potential Anti-diabetic Drug." Thesis, Virginia Tech, 2012. http://hdl.handle.net/10919/19202.
Pełny tekst źródłaHamrén, Bengt. "Safety and Efficacy Modelling in Anti-Diabetic Drug Development." Doctoral thesis, Uppsala University, Division of Pharmacokinetics and Drug Therapy, 2008. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-8648.
Pełny tekst źródłaVanderMeulen, Heather. "Potential anti-inflammatory properties of the diabetic drug metformin." Thesis, McGill University, 2014. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=123091.
Pełny tekst źródłaOu, Peimian. "Possible mechanisms for oxidative damage in diabetes mellitus and of some anti-diabetes drugs." Thesis, University College London (University of London), 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.243381.
Pełny tekst źródłaCraythorne, Natalie Louise. "Nanoparticles as potential drug delivery systems for anti-diabetic peptide therapeutics." Thesis, Ulster University, 2014. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.650084.
Pełny tekst źródłaAlgire, Carolyn. "Impact of the anti-diabetic drug metformin on tumor growth «in vivo»." Thesis, McGill University, 2011. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=103469.
Pełny tekst źródłaTam, Teresa. "The effects of Cree anti-diabetic natural health products on drug metabolism and cardiomyocytes." Thesis, University of Ottawa (Canada), 2009. http://hdl.handle.net/10393/28230.
Pełny tekst źródłaGedawy, Ahmed Abou Bakr Gaber. "Innovative platforms for oral microencapsulation formulation and drug analytical techniques for anti-diabetics." Thesis, Curtin University, 2020. http://hdl.handle.net/20.500.11937/81966.
Pełny tekst źródłaKsiążki na temat "Anti diabetic drugs"
Yŏm, Yŏng-il. Chŏnsachʻe pʻŭropʻail ŭl iyong han hang tangnyo chagyong kijŏn kŏmjŭng yŏnʼgu =: Study of the action mechanism of anti-diabetic drugs by transcriptome profiling. Sikpʻum Ŭiyakpʻum Anjŏnchʻŏng, 2007.
Znajdź pełny tekst źródłaCanadian Coordinating Office for Health Technology Assessment., ed. Comparative clinical and budget evaluations of rosiglitazone and pioglitazone with other anti-diabetic agents. Canadian Coordinating Office for Health Technology Assessment, 2003.
Znajdź pełny tekst źródłaPharm, Boucher Michel B., and Canadian Coordinating Office for Health Technology Assessment., eds. Efficacy of rosiglitazone and pioglitazone compared to other anti-diabetic agents: Systematic review and budget impact analysis. Canadian Coordinating Office for Health Technology Assessment, 2002.
Znajdź pełny tekst źródłaPharm, Boucher Michel B., and Canadian Coordinating Office for Health Technology Assessment., eds. Efficacy of rosiglitazone and pioglitazone compared to other anti-diabetic agents: Systematic review and budget impact analysis. Canadian Coordinating Office for Health Technology Assessment, 2002.
Znajdź pełny tekst źródłaMedicinal Plants: Promising Future for Health and New Drugs. Taylor & Francis Group, 2018.
Znajdź pełny tekst źródłaKuroedov, Alexey. Role of protein kinase C[beta] inhibitors and glycogen synthase kinase-3 inhibitors, new anti-diabetic drugs, in preventing atherogenic transformation of monocytes and endothelial activation. 2007.
Znajdź pełny tekst źródłaLi, Jie Jack. Laughing Gas, Viagra, and Lipitor. Oxford University Press, 2006. http://dx.doi.org/10.1093/oso/9780195300994.001.0001.
Pełny tekst źródłaGhani, Usman. Alpha-Glucosidase Inhibitors: Promising Candicates for Anti-Diabetic Drug Discovery. Elsevier, 2019.
Znajdź pełny tekst źródłaGhani, Usman. Alpha-Glucosidase Inhibitors: Clinically Promising Candidates for Anti-Diabetic Drug Discovery. Elsevier, 2019.
Znajdź pełny tekst źródłaJones, Roy W. Pharmacological treatment of dementia. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199644957.003.0038.
Pełny tekst źródłaCzęści książek na temat "Anti diabetic drugs"
Falcomatà, B., Maurizio Battaglia Parodi, P. Iacono, G. Guarnaccia, and F. Bandello. "Use of Anti-Vascular Endothelial Growth Factor Drugs for Diabetic Macular Edema." In Surgical Retina. S. KARGER AG, 2012. http://dx.doi.org/10.1159/000338155.
Pełny tekst źródłaRao, Madhushree M. V., Likith M, Gayathri D S, Ravikumar H, and Hariprasad T P N. "Bioinformatics Tools for the Discovery of Potential Anti-Diabetic Drugs from Lichens." In Computational Approaches in Biotechnology and Bioinformatics. CRC Press, 2024. http://dx.doi.org/10.1201/9781003354437-10.
Pełny tekst źródłaChen, Shyi-Ming, Yun-Hou Huang, Rung-Ching Chen, Szu-Wei Yang, and Tian-Wei Sheu. "Using Fuzzy Reasoning Techniques and the Domain Ontology for Anti-Diabetic Drugs Recommendation." In Intelligent Information and Database Systems. Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-28487-8_13.
Pełny tekst źródłaThangaraj, Parimelazhagan. "Anti-diabetic Activity." In Progress in Drug Research. Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-26811-8_23.
Pełny tekst źródłaThangaraj, Parimelazhagan. "Evaluation of Anti-diabetic Property on Streptozotocin-Induced Diabetic Rats." In Progress in Drug Research. Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-26811-8_24.
Pełny tekst źródłaVeni, T., T. Pushpanathan, and G. Vimala. "Plant Constituent as Anti-Cancer Drugs." In Drug Development for Cancer and Diabetes. Apple Academic Press, 2020. http://dx.doi.org/10.1201/9780429330490-5.
Pełny tekst źródłaPal, Sarbani, and Manojit Pal. "Anti-diabetes Research in India: Contributions from Industrial Organizations." In Drug Discovery and Drug Development. Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-15-8002-4_8.
Pełny tekst źródłaMukerji, Geetha, and Denice S. Feig. "Advances in Oral Anti-Diabetes Drugs in Pregnancy." In A Practical Manual of Diabetes in Pregnancy. John Wiley & Sons, Ltd, 2017. http://dx.doi.org/10.1002/9781119043805.ch15.
Pełny tekst źródłaArch, Jonathan R. S. "Thermogenesis and Related Metabolic Targets in Anti-Diabetic Therapy." In Diabetes - Perspectives in Drug Therapy. Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-17214-4_10.
Pełny tekst źródłaMtewa, Andrew G., Duncan Sesaazi, Amanjotannu, and Serawit Deyno. "Essential Drug Properties and Stages in Anti-Cancer Drug Development." In Drug Development for Cancer and Diabetes. Apple Academic Press, 2020. http://dx.doi.org/10.1201/9780429330490-4.
Pełny tekst źródłaStreszczenia konferencji na temat "Anti diabetic drugs"
Alkawari, Fatima, Wigdan Ali, Fatiha Benslimane, and Huseyin Yalcin. "Investigating the Cardiac effects of New Generation Anti-Diabetic Drug Empagliflozin using Zebrafish Embryo Model." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2020. http://dx.doi.org/10.29117/quarfe.2020.0211.
Pełny tekst źródłaChen, Rung-Ching, Cho-Tsan Bau, and Yun-Hou Huang. "Development of anti-diabetic drugs ontology for guideline-based clinical drugs recommend system using OWL and SWRL." In 2010 IEEE International Conference on Fuzzy Systems (FUZZ-IEEE). IEEE, 2010. http://dx.doi.org/10.1109/fuzzy.2010.5584139.
Pełny tekst źródłaMujahid, A., I. Haq, T. Hussain, S. Z. Bajwa, and A. Afzal. "P2BM.6 - Tailoring Molecular Imprinted Polymers as Biomimetic Recognition Coatings for Anti-Diabetic Drugs." In 17th International Meeting on Chemical Sensors - IMCS 2018. AMA Service GmbH, Von-Münchhausen-Str. 49, 31515 Wunstorf, Germany, 2018. http://dx.doi.org/10.5162/imcs2018/p2bm.6.
Pełny tekst źródłaContreras, U., N. Ornelas-Soto, M. A. Meneses-Nava, O. Barbosa-García, P. L. López-de-Alba, and L. López-Martínez. "Rapid screening for quality control and adulteration in anti-diabetic drugs: quantitative and qualitative analysis by LIBS." In Applied Industrial Optics: Spectroscopy, Imaging and Metrology. OSA, 2010. http://dx.doi.org/10.1364/aio.2010.amc3.
Pełny tekst źródłaLoisay, L., S. Bouagga, A. Antoniadis, T. Hügle, and J. Geurts. "POS0794 ANTI-DIABETIC DRUGS TARGET SUBCHONDRAL MARROW ADIPOSE TISSUE METABOLISM IN A PRECLINICAL MODEL OF KNEE OSTEOARTHRITIS." In EULAR 2024 European Congress of Rheumatology, 12-15 June. Vienna, Austria. BMJ Publishing Group Ltd and European League Against Rheumatism, 2024. http://dx.doi.org/10.1136/annrheumdis-2024-eular.6122.
Pełny tekst źródłaNishat, Zurwa, Tara Pellegrino, and Robert Steer. "Outcomes in Type II Diabetes Patients through the Covid 19 Pandemic A Retrospective Chart Review." In 27th Annual Rowan-Virtua Research Day. Rowan University Libraries, 2023. https://doi.org/10.31986/issn.2689-0690_rdw.stratford_research_day.54_2023.
Pełny tekst źródłaCarvalho, Ana Cláudia Pires, Fernanda Rezende Dias, Luisa Crevelin Costa, and Natália de Castro Fim Nakao. "Myopathy following statin use." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.512.
Pełny tekst źródłaJakhotia, Sneha, Branislav Nastasijević, Gordana Joksić, Sreenivasa Reddy, and G. Bhanuprakash Reddy. "Gentiana lutea AND DIABETIC COMPLICATIONS." In 8th Workshop Food and Drug Safety and Qualit. Vinča Institute of Nuclear Sciences - National Institute of the Republic of Serbia, 2024. http://dx.doi.org/10.46793/8fdsq.ild1sj.
Pełny tekst źródłaFalabella, Petra, and Željka Večerić-Haler. "Arginine Vasopressin Resistance (AVP-R)." In Socratic Lectures 11. University of Lubljana Press, 2024. http://dx.doi.org/10.55295/psl.11.2024.1.
Pełny tekst źródłaChristopher, Devasahayam Jesudas, Deva Jedidiah, Barney Isaac, Binu Mathew, and Blessed Winston. "Anti-tubercular drug concentrations in Pulmonary Tuberculosis patients - Diabetic vs Non-Diabetic groups." In ERS International Congress 2019 abstracts. European Respiratory Society, 2019. http://dx.doi.org/10.1183/13993003.congress-2019.pa2999.
Pełny tekst źródłaRaporty organizacyjne na temat "Anti diabetic drugs"
Jin, Dachuan, Gao Peng, Shunqin Jin, Tao Zhou, Baoqiang Guo, and Guangming Li. Comparison of therapeutic effects of anti-diabetic drugs on non-alcoholic fatty liver disease patients without diabetes: A network meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.11.0014.
Pełny tekst źródłaJiang, Yang, Wei He, and Shi-xin Qi. Evaluating the efficacy of subthreshold micropulse laser combined with anti-VEGF drugs in the treatment of diabetic macular edema: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2024. https://doi.org/10.37766/inplasy2024.12.0068.
Pełny tekst źródłaPiao, Tianhua, Hongyang Ma, and Rui Wang. Comparison Between Ozurdex and TA as An Adjunct Drug Combined with Intravitreal anti-VEGF Treatment for Diabetic Macular Edema: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.6.0027.
Pełny tekst źródła